高级搜索
超选择髂内动脉插管治疗中晚期卵巢癌[J]. 肿瘤防治研究, 1997, 24(6): 380-382.
引用本文: 超选择髂内动脉插管治疗中晚期卵巢癌[J]. 肿瘤防治研究, 1997, 24(6): 380-382.
Treatment of Advanced and Recurrent Ovarian Cancer with Superelective Catheterization of internal Iliac Artery[J]. Cancer Research on Prevention and Treatment, 1997, 24(6): 380-382.
Citation: Treatment of Advanced and Recurrent Ovarian Cancer with Superelective Catheterization of internal Iliac Artery[J]. Cancer Research on Prevention and Treatment, 1997, 24(6): 380-382.

超选择髂内动脉插管治疗中晚期卵巢癌

Treatment of Advanced and Recurrent Ovarian Cancer with Superelective Catheterization of internal Iliac Artery

  • 摘要: 目的:探讨超选择髂内动脉插管治疗中晚期卵巢癌的疗效及其影响因素。方法:对31例中晚期卵巢癌进行双侧髂内动脉超选择化疗并栓塞83次, 全部病例均经随访。 结果:近期疗效较好, 有效率为77.4%。 结论:超选择髂内动脉插管是治疗中晚期卵巢癌的一种新而有效的方法, 影响疗效的因素有:①导管能否超选择; ②肿瘤的大小、临床分期及血管构型; ③药物及栓塞材料的选择; ①病人的自身情况。

     

    Abstract: Objective: To investigate the effect of the treatment for advanced and recurrent ovarian cancer with superelective catheterization of internal iliac arteries and the factors influencing therapeutic effect. Methods: The arterial perfusion chemotherapy and embolization by superelective catheterization of both internal iliac arteries on 31 patients with advanced and recurrent ovarian cancer have been completed for 83 times. Results: All cases were followed-up. A good short-term effectiveness was gained. The immediate effective rate was 77.4%. Conclusions: The superelective catheterization of internal iliac artery is a new and effective method for treatment of advanced and recurrent ovarian cancer. Factors influencing therapeutic effects were: (1) Whether or not superselection for catheterization. (2) Size and clinical stage of the tumour, and structural type of tumourous vasa. (3) Selection of drugs and embolic meteriats. (4) The status of the patients themselves.

     

/

返回文章
返回